Non Viral In-Vivo CAR – Engineering with Episomal DNA: The Next Frontier for Off-the-Shelf & Scalable Cell Therapy
- Creating a third path to in-vivo CAR-T
- Highlight emerging preclinical evidence demonstrating feasibility and efficacy
New Data
24-26 February, 2025 | London, UK
24-26 February, 2025 | London, UK